BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242:644-648. [PMID: 221698 DOI: 10.1001/jama.242.7.644] [Cited by in Crossref: 66] [Cited by in F6Publishing: 42] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Hannaford PC, Kay CR, Vessey MP, Painter R, Mant J. Combined oral contraceptives and liver disease. Contraception 1997;55:145-51. [DOI: 10.1016/s0010-7824(97)00023-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Aseni P, Sansalone CV, Sammartino C, Benedetto FD, Carrafiello G, Giacomoni A, Osio C, Vertemati M, Forti D. Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol. 2001;33:234-236. [PMID: 11500616 DOI: 10.1097/00004836-200109000-00015] [Cited by in Crossref: 58] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
3 Grimes DA, Schulz KF. Clinical Research in Obstetrics and Gynecology:: A Baedeker for Busy Clinicians. Obstetrical & Gynecological Survey 2002;57:S35-53. [DOI: 10.1097/00006254-200209003-00001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
4 Seibert B, Günzel P. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna®. Contraception 1994;49:303-33. [DOI: 10.1016/0010-7824(94)90030-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
5 Cramer D, Cann C. Risks and benefits of oral contraceptive use in women over 35. Maturitas 1988;10:99-109. [DOI: 10.1016/0378-5122(88)90012-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
6 Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, Dhumeaux D. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000;118:560-564. [PMID: 10702207 DOI: 10.1016/s0016-5085(00)70262-9] [Cited by in Crossref: 166] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
7 Kogure K, Nagamachi Y, Sasamoto K, Ogawa T. Liver cell adenoma: A case report and a review of 30 cases reported in Japan. J Gastroenterol Hepatol 1987;2:325-31. [DOI: 10.1111/j.1440-1746.1987.tb00170.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Verslype C, Libbrecht L. The diagnostic and therapeutic approach for primary solid liver tumours in adults. Best Practice & Research Clinical Gastroenterology 2007;21:983-96. [DOI: 10.1016/j.bpg.2007.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
9 Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48:163-170. [PMID: 17997499 DOI: 10.1016/j.jhep.2007.10.003] [Cited by in Crossref: 166] [Cited by in F6Publishing: 124] [Article Influence: 11.1] [Reference Citation Analysis]
11 Lewis RB, Lattin GE Jr, Makhlouf HR, Levy AD. Tumors of the liver and intrahepatic bile ducts: radiologic-pathologic correlation. Magn Reson Imaging Clin N Am 2010;18:587-609, xii. [PMID: 21094457 DOI: 10.1016/j.mric.2010.08.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
12 Shaw RW. Adverse long-term effects of oral contraceptives: a review. BJOG:An international journal of O&G 1987;94:724-30. [DOI: 10.1111/j.1471-0528.1987.tb03716.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
13 Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol. 2001;25:1388-1396. [PMID: 11684955 DOI: 10.1097/00000478-200111000-00006] [Cited by in Crossref: 100] [Cited by in F6Publishing: 90] [Article Influence: 4.8] [Reference Citation Analysis]
14 Klompenhouwer AJ, de Man RA, Thomeer MG, Ijzermans JN. Management and outcome of hepatocellular adenoma with massive bleeding at presentation. World J Gastroenterol 2017; 23(25): 4579-4586 [PMID: 28740346 DOI: 10.3748/wjg.v23.i25.4579] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
15 Chitturi S, Farrell GC. Drug-Induced Liver Disease. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 703-83. [DOI: 10.1002/9781119950509.ch27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Rosenberg L. The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception. 1991;43:643-652. [PMID: 1651205 DOI: 10.1016/0010-7824(91)90007-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis]
17 Brown RS Jr. Asymptomatic liver mass. Gastroenterology 2006;131:619-23. [PMID: 16890613 DOI: 10.1053/j.gastro.2006.06.020] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
18 Giusti S, Donati F, Paolicchi A, Bartolozzi C. Hepatocellular adenoma: imaging findings and pathological correlation. Dig Liver Dis 2005;37:200-5. [PMID: 15888286 DOI: 10.1016/j.dld.2004.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
19 Erdogan D, Busch OR, van Delden OM, Ten Kate FJ, Gouma DJ, van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int. 2006;26:433-438. [PMID: 16629646 DOI: 10.1111/j.1478-3231.2005.01244.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Hardy KJ. Focal nodular hyperplasia. Aust N Z J Surg 1992;62:833-5. [PMID: 20169698 DOI: 10.1111/j.1445-2197.1992.tb06934.x] [Reference Citation Analysis]
21 Rao T, Allen B, Cox J, Epler J. Enhancement of mutagenic activity in Salmonella by contraceptive steroids. Toxicology and Applied Pharmacology 1983;69:48-54. [DOI: 10.1016/0041-008x(83)90118-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
22 Cohen C, Lawson D, Derose PB. Sex and androgenic steroid receptor expression in hepatic adenomas. Human Pathology 1998;29:1428-32. [DOI: 10.1016/s0046-8177(98)90011-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
23 Buell JF, Tranchart H, Cannon R, Dagher I. Management of Benign Hepatic Tumors. Surgical Clinics of North America 2010;90:719-35. [DOI: 10.1016/j.suc.2010.04.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
24 Ghia M, Mereto E. Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations. Cancer Lett 1989;46:195-202. [PMID: 2569927 DOI: 10.1016/0304-3835(89)90130-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
25 Hilal MA, Fabio FD, Wiltshire RD, Hamdan M, Layfield DM, Pearce NW. Laparoscopic liver resection for hepatocellular adenoma. World J Gastrointest Surg 2011; 3(7): 101-105 [PMID: 21860698 DOI: 10.4240/wjgs.v3.i7.101] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
26 Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience. Hepatol Res. 2011;41:982-988. [PMID: 21883740 DOI: 10.1111/j.1872-034x.2011.00851.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
27 Shaked O, Reddy KR. Approach to a Liver Mass. Clinics in Liver Disease 2009;13:193-210. [DOI: 10.1016/j.cld.2009.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Boutros C, Katz SC, Espat NJ. Management of an incidental liver mass. Surg Clin North Am. 2010;90:699-718. [PMID: 20637942 DOI: 10.1016/j.suc.2010.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Suárez-Peñaranda JM, de la Calle MC, Rodrìguez-Calvo MS, Muñoz JI, Concheiro L. Rupture of liver cell adenoma with fatal massive hemoperitoneum resulting from minor road accident. Am J Forensic Med Pathol 2001;22:275-7. [PMID: 11563739 DOI: 10.1097/00000433-200109000-00015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
30 Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006;1089:228-236. [PMID: 17261770 DOI: 10.1196/annals.1386.044] [Cited by in Crossref: 176] [Cited by in F6Publishing: 147] [Article Influence: 11.7] [Reference Citation Analysis]
31 Li JJ, Kirkman H, Li SA. Synthetic Estrogens and Liver Cancer: Risk Analysis of Animal and Human Data. In: Li JJ, Nandi S, Li SA, editors. Hormonal Carcinogenesis. New York: Springer; 1992. pp. 217-24. [DOI: 10.1007/978-1-4613-9208-8_28] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
32 Hartmann BW, Huber JC. The mythology of hormone replacement therapy. Br J Obstet Gynaecol 1997;104:163-8. [PMID: 9070132 DOI: 10.1111/j.1471-0528.1997.tb11038.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
33 Lewis JH. Drug-induced liver disease. Med Clin North Am. 2000;84:1275-1311, x. [PMID: 11026929 DOI: 10.1016/s0025-7125(05)70287-x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
34 Bunchorntavakul C, Bahirwani R, Drazek D, Soulen MC, Siegelman ES, Furth EE, Olthoff K, Shaked A, Reddy KR. Clinical features and natural history of hepatocellular adenomas: the impact of obesity: Hepatocellular adenomas and obesity. Alimentary Pharmacology & Therapeutics 2011;34:664-74. [DOI: 10.1111/j.1365-2036.2011.04772.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
35 Erdogan D, Busch OR, van Delden OM, Ten Kate FJ, Gouma DJ, van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int. 2006;26:433-438. [PMID: 16629646 DOI: 10.1111/j.1478-3231.2006.01244.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
36 Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and Clinical Features of Benign Solid and Cystic Lesions of the Liver. Clinical Gastroenterology and Hepatology 2011;9:547-562.e4. [DOI: 10.1016/j.cgh.2011.03.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
37 Kim TY, Kim BS, Hyun CL, Song BC. [Hepatocellular adenoma treated with radiofrequency ablation in young male]. Korean J Gastroenterol. 2011;57:384-387. [PMID: 21694493 DOI: 10.4166/kjg.2011.57.6.384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
38 Altmann HW. Hepatic neoformations. Pathol Res Pract. 1994;190:513-577. [PMID: 7984516 DOI: 10.1016/s0344-0338(11)80394-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Goldzieher JW, Zamah NM. Oral contraceptive side effects: Where's the beef? Contraception 1995;52:327-35. [DOI: 10.1016/0010-7824(95)00222-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
40 Fujita S, Kushihata F, Herrmann GE, Mergo PJ, Liu C, Nelson D, Fujikawa T, Hemming AW. Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol. 2006;21:1351-1354. [PMID: 16872326 DOI: 10.1111/j.1440-1746.2006.03184.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
41 Machnik G, Chemnitius K, Niekrenz H. Liver neoplasms after long-term steroid application in rats. Experimental Pathology 1983;24:183-7. [DOI: 10.1016/s0232-1513(83)80031-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
42 Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am. 1998;36:319-331. [PMID: 9520985 DOI: 10.1016/s0033-8389(05)70025-7] [Cited by in Crossref: 101] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
43 Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137:1698-1705. [PMID: 19664629 DOI: 10.1053/j.gastro.2009.07.061] [Cited by in Crossref: 266] [Cited by in F6Publishing: 199] [Article Influence: 20.5] [Reference Citation Analysis]
44 Corfman PA. Labeling guidance for combination oral contraceptives. Contraception 1988;37:433-55. [DOI: 10.1016/0010-7824(88)90015-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]